Medis Group

Medis Group is a Tunisian pharmaceutical company focused on the development, manufacture, and commercialization of branded generic and specialty medicines. The company has a broad marketed portfolio spanning oral solid dose products, sterile injectables, and branded therapies used across chronic disease and hospital settings. Its therapeutic coverage includes cardiometabolic disease, gastroenterology, pain, allergy, oncology, and other specialty areas, with operations centered in Tunisia and Algeria and additional expansion into Francophone Africa. Medis has invested in sterile manufacturing and oncology-focused capabilities, and has articulated ambitions in more complex products such as biosimilars and inhaled therapies. The business appears to be a fully commercial-stage regional pharma manufacturer rather than a clinical-stage biotech developer.